14-day Premium Trial Subscription Try For FreeTry Free
$2.25
+0.0900 (+4.17%)
At Close: May 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Feb 23, 2024 Buy 250 000 Luci David P Stock Option
Feb 23, 2024 Buy 145 000 Shawah Robert G. Stock Option
Feb 23, 2024 Buy 250 000 Deluccia Robert J Stock Option
Jan 19, 2024 Buy 19 737 Sailer Carl Common Stock
Jan 19, 2024 Sell 19 737 Sailer Carl Warrants for Common Stock
Jan 03, 2024 Buy 19 737 Deluccia Robert J Common Stock
Jan 03, 2024 Sell 19 737 Deluccia Robert J Warrants for Common Stock
Jan 03, 2024 Buy 19 737 Luci David P Common Stock
Jan 03, 2024 Sell 19 737 Luci David P Warrants for Common Stock
Dec 22, 2023 Sell 30 000 Deluccia Robert J Common Stock
Dec 12, 2023 Sell 40 000 Deluccia Robert J Common Stock
Jun 15, 2023 Buy 10 000 Donohue James J. Stock Option
Jun 15, 2023 Buy 10 000 Harrison Thomas L Stock Option
Jun 15, 2023 Buy 10 000 Dean Jack H Stock Option
Jun 15, 2023 Buy 10 000 Sailer Carl Stock Option
Jun 15, 2023 Buy 10 000 Scodari Joseph C Stock Option
Feb 13, 2023 Buy 75 000 Shawah Robert G. Stock Option
Feb 13, 2023 Buy 130 000 Luci David P Stock Option
Feb 13, 2023 Buy 130 000 Deluccia Robert J Stock Option
Jul 27, 2022 Buy 19 737 Sailer Carl Warrants for Common Stock
Jul 27, 2022 Buy 19 737 Deluccia Robert J Common Stock
Jul 27, 2022 Buy 19 737 Deluccia Robert J Warrants for Common Stock
Jul 27, 2022 Buy 19 737 Deluccia Robert J Warrants for Common Stock
Jul 27, 2022 Buy 19 737 Luci David P Warrants for Common Stock
Dec 02, 2021 Sell 40 000 Deluccia Robert J Common Stock
Nov 23, 2021 Buy 5 161 Sailer Carl Common Stock
Nov 19, 2021 Buy 5 034 Deluccia Robert J Common Stock
Nov 19, 2021 Buy 5 200 Luci David P Common Stock
Jul 01, 2021 Buy 50 000 Scodari Joseph C Stock Option
Jul 01, 2021 Buy 50 000 Sailer Carl Stock Option
Jul 01, 2021 Buy 50 000 Harrison Thomas L Stock Option
Jul 01, 2021 Buy 50 000 Donohue James J. Stock Option
Jul 01, 2021 Buy 50 000 Dean Jack H Stock Option
Jul 01, 2021 Buy 500 000 Luci David P Stock Option
Jul 01, 2021 Buy 200 000 Shawah Robert G. Stock Option
Jul 01, 2021 Buy 500 000 Deluccia Robert J Stock Option
Jun 29, 2021 Buy 12 500 Sailer Carl Common Stock
Jun 29, 2021 Buy 350 000 Luci David P Stock Option
Jun 29, 2021 Buy 70 000 Shawah Robert G. Stock Option
Jun 29, 2021 Buy 350 000 Deluccia Robert J Stock Option
Jun 24, 2021 Buy 0 Donohue James J. Common Stock
Jun 24, 2021 Buy 0 Harrison Thomas L Common Stock
Jun 24, 2021 Buy 0 Scodari Joseph C Common Stock
Jun 24, 2021 Buy 0 Dean Jack H Common Stock
Jun 24, 2021 Buy 0 Dean Jack H Common Stock
Jun 24, 2021 Buy 0 Luci David P Common Stock
Jun 24, 2021 Buy 0 Luci David P Common Stock
Jun 24, 2021 Buy 0 Luci David P Common Stock
Jun 24, 2021 Buy 0 Sailer Carl Common Stock
Jun 24, 2021 Buy 0 Sailer Carl Common Stock
Jun 24, 2021 Buy 0 Shawah Robert G. Common Stock
Jun 24, 2021 Buy 0 Deluccia Robert J Common Stock
Jun 24, 2021 Buy 0 Deluccia Robert J Common Stock
Oct 18, 2019 Buy 3 125 Deluccia Robert J Warrants for Common Stock
Aug 08, 2019 Buy 1 875 Dean Jack H Warrants for Common Stock
Aug 08, 2019 Buy 3 125 Sailer Carl Warrants for Common Stock
Aug 08, 2019 Buy 625 Shawah Robert G. Warrants for Common Stock
Mar 29, 2019 Buy 3 125 Luci David P Warrants for Common Stock
Oct 23, 2018 Buy 7 500 Luci David P Warrants for Common Stock
Oct 23, 2018 Buy 4 167 Sailer Carl Warrants for Common Stock
Oct 23, 2018 Buy 8 334 Deluccia Robert J Warrants for Common Stock
Mar 20, 2018 Buy 6 250 Donohue James J. Warrants for Common Stock
Mar 20, 2018 Buy 3 125 Dean Jack H Warrants for Common Stock
Mar 20, 2018 Buy 6 250 Luci David P Warrants for Common Stock
Mar 20, 2018 Buy 6 250 Sailer Carl Warrants for Common Stock
Mar 20, 2018 Buy 6 250 Deluccia Robert J Warrants for Common Stock
JSON CSV
INSIDER POWER
67.831
Last 66 transactions
Buy: 3 495 792 | Sell: 169 211 (Shares)

Based on the 66 latest insides trades, we have calculated the insider power to be positive at a ratio of 67.831.

In total, the insiders bought 3 495 792 and sold 169 211 ACXP shares in the last 66 trades.

Click to get the best stock tips daily for free!

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals. Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bac... ACXP Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT